Sugi Predict

Sugi Predict / Compounds / SCHEMBL25818438

SCHEMBL25818438

SCHEMBL25818438

Clc1nc(-c2cccc(-c3ccc4cc(-c5ccc6ccccc6c5)ccc4c3)c2)nc(-c2ccc3c(c2)oc2ccccc23)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 2/20 0.44
▸ HCRTR1 O43613 1/20 0.41
▸ HSD17B1 P14061 2/20 0.38
▸ HSD17B2 P37059 2/20 0.38
▸ PLA2G2A P14555 2/20 0.37
▸ PLA2G4A P47712 2/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CYP17A1 P05093 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818551 0.99 AHR (0.43) AHRHCRTR1HSD17B1HSD17B2PLA2G2A
SCHEMBL25818396 0.95 AHR (0.44) AHRHCRTR1PLA2G2APLA2G4AMEN1
SCHEMBL30512300 0.95 AHR (0.49) AHRHCRTR1MEN1KMT2AKDM4E
SCHEMBL20894572 0.95 AHR (0.49) AHRHCRTR1MEN1KMT2AKDM4E
SCHEMBL25818487 0.94 AHR (0.43) AHRHCRTR1PLA2G2APLA2G4AMEN1
SCHEMBL25818553 0.94 AHR (0.43) AHRHCRTR1PLA2G2APLA2G4AMEN1
SCHEMBL26271585 0.93 HCRTR1 (0.45) AHRHCRTR1HSD17B1HSD17B2PLA2G2A
SCHEMBL21108995 0.93 HCRTR1 (0.45) AHRHCRTR1HSD17B1HSD17B2PLA2G2A
SCHEMBL25817808 0.93 HCRTR1 (0.45) AHRHCRTR1HSD17B1HSD17B2PLA2G2A
SCHEMBL26448191 0.93 HCRTR1 (0.45) AHRHCRTR1HSD17B1HSD17B2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 AHR 971/4885HCRTR1 3557/4885HSD17B1 3460/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 AHR 971/4885HCRTR1 3557/4885HSD17B1 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.